Wall Street brokerages expect NCS Multistage Holdings Inc (NASDAQ:NCSM) to announce sales of $39.07 million for the current quarter, Zacks reports. Four analysts have issued estimates for NCS Multistage’s earnings. The highest sales estimate is $42.00 million and the lowest is $37.70 million. NCS Multistage posted sales of $43.40 million in the same quarter last year, which suggests a negative year over year growth rate of 10%. The company is scheduled to report its next quarterly earnings results on Tuesday, August 6th.
According to Zacks, analysts expect that NCS Multistage will report full year sales of $204.18 million for the current fiscal year, with estimates ranging from $200.22 million to $212.43 million. For the next financial year, analysts anticipate that the business will post sales of $246.23 million, with estimates ranging from $239.00 million to $253.99 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow NCS Multistage.
NCS Multistage (NASDAQ:NCSM) last issued its quarterly earnings results on Monday, May 6th. The company reported ($0.04) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.04). The business had revenue of $52.85 million during the quarter, compared to analyst estimates of $54.65 million. NCS Multistage had a negative net margin of 101.98% and a negative return on equity of 1.11%.
Shares of NCS Multistage stock traded down $0.15 during midday trading on Friday, reaching $2.58. The company had a trading volume of 102,634 shares, compared to its average volume of 116,273. The company has a debt-to-equity ratio of 0.14, a current ratio of 5.44 and a quick ratio of 3.72. The firm has a market cap of $126.01 million, a P/E ratio of 12.95 and a beta of 2.16. NCS Multistage has a 1-year low of $2.46 and a 1-year high of $17.63.
In other news, CFO Ryan Hummer purchased 50,000 shares of NCS Multistage stock in a transaction dated Tuesday, May 28th. The shares were bought at an average cost of $2.61 per share, with a total value of $130,500.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Franklin Myers purchased 40,000 shares of NCS Multistage stock in a transaction dated Friday, May 24th. The shares were purchased at an average cost of $2.57 per share, for a total transaction of $102,800.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 140,000 shares of company stock worth $364,800. Insiders own 11.90% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of Montreal Can boosted its position in shares of NCS Multistage by 712.8% during the first quarter. Bank of Montreal Can now owns 5,251 shares of the company’s stock worth $27,000 after purchasing an additional 4,605 shares in the last quarter. Paloma Partners Management Co bought a new position in shares of NCS Multistage during the fourth quarter worth $64,000. Rhumbline Advisers bought a new position in shares of NCS Multistage during the fourth quarter worth $73,000. Energy Opportunities Capital Management LLC bought a new position in shares of NCS Multistage during the fourth quarter worth $76,000. Finally, M&T Bank Corp bought a new position in shares of NCS Multistage during the first quarter worth $83,000. 90.77% of the stock is currently owned by institutional investors.
About NCS Multistage
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.
Featured Story: Diluted Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.